Semax and Selank bypass the BBB entirely through intranasal administration, reaching the brain via the olfactory pathway
Phase III Clinical Research Trials Once enough data is collected from Phase II trials the drug will be approved to proceed into Phase III
When this barrier is disrupted, RPE cell activation occurs, leading to the proliferation, epithelial-mesenchymal transition (EMT), and secretion of extracellular matrix molecules, thus promoting vitreoretinal disorders, including proliferative vitreoretinopathy (PVR), age-related macular degeneration (AMD), and proliferative diabetic retinopathy (PDR) [1,2,3]
Calculate total protocol cost using the peptide cost calculator
Explore GHK-Cu Therapy Why Are These Peptides Combined
An unusual feature reported in the literature is timing: in some studies, DSIP given during the day was associated with improved sleep that night , rather than acting as an immediate, bedtime sedative